Triptorelin Pamoate Patent Expiration

Triptorelin Pamoate was first introduced by Verity Pharmaceuticals Inc in its drug Trelstar on Jun 15, 2000. Another drug containing Triptorelin Pamoate is Triptodur Kit. 2 different companies have introduced drugs containing Triptorelin Pamoate.


Triptorelin Pamoate Patents

Given below is the list of patents protecting Triptorelin Pamoate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trelstar US10166181 Slow release pharmaceutical composition made of microgranules Jun 30, 2029 Verity
Triptodur Kit US10166181 Slow release pharmaceutical composition made of microgranules Jun 30, 2029 Azurity
Trelstar US5776885 Sustained and controlled release of water insoluble polypeptides Jul 07, 2015

(Expired)

Verity



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Triptorelin Pamoate's patents.

Given below is the list recent legal activities going on the following patents of Triptorelin Pamoate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 01 Jul, 2022 US10166181
Post Issue Communication - Certificate of Correction 08 Jan, 2020 US10166181
Email Notification 27 Sep, 2019 US10166181
Mail-Petition Decision - Dismissed 24 Sep, 2019 US10166181
Petition Decision - Dismissed 23 Sep, 2019 US10166181
Email Notification 06 Mar, 2019 US10166181
Change in Power of Attorney (May Include Associate POA) 06 Mar, 2019 US10166181
Petition Entered 25 Feb, 2019 US10166181
Patent Issue Date Used in PTA Calculation 01 Jan, 2019 US10166181
Recordation of Patent Grant Mailed 01 Jan, 2019 US10166181


Triptorelin Pamoate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List